# BioNexus Gene Lab Corp: Form 8-K, filed Oct 8, 2020

- Company: [BioNexus Gene Lab Corp](/companies/bglc.md) (CIK 1737523)
- Form: 8-K
- Filed: 2020-10-08
- Accepted by EDGAR: Oct 8, 2020, 15:32 ET
- Period: 2020-10-01
- Accession: 0001477932-20-005798
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1737523/000147793220005798/bion_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737523/000147793220005798/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737523/000147793220005798/bion_8k.htm

Filed Oct 8, 2020.
Source: SEC EDGAR, the filing index for accession 0001477932-20-005798. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
